• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.肌球蛋白轻链激酶敲除可改善肠道屏障功能,并在多微生物脓毒症中提供生存优势。
Mol Med. 2017 Aug;23:155-165. doi: 10.2119/molmed.2016.00256. Epub 2017 Jun 7.
2
Membrane Permeant Inhibitor of Myosin Light Chain Kinase Worsens Survival in Murine Polymicrobial Sepsis.肌球蛋白轻链激酶膜通透抑制剂在小鼠多微生物脓毒症中恶化生存。
Shock. 2021 Oct 1;56(4):621-628. doi: 10.1097/SHK.0000000000001759.
3
TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.TNFR2 通过激活 MLCK 依赖性紧密连接调节障碍导致细胞凋亡介导的屏障缺失和实验性结肠炎。
Gastroenterology. 2013 Aug;145(2):407-15. doi: 10.1053/j.gastro.2013.04.011. Epub 2013 Apr 22.
4
Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.肌球蛋白轻链激酶在缺氧/复氧损伤期间通过闭锁蛋白内吞作用介导肠道屏障功能障碍。
Am J Physiol Cell Physiol. 2016 Dec 1;311(6):C996-C1004. doi: 10.1152/ajpcell.00113.2016. Epub 2016 Oct 19.
5
MYOSIN LIGHT CHAIN KINASE DELETION WORSENS LUNG PERMEABILITY AND INCREASES MORTALITY IN PNEUMONIA-INDUCED SEPSIS.肌球蛋白轻链激酶缺失可加重肺炎诱导性脓毒症的肺通透性并增加死亡率。
Shock. 2023 Apr 1;59(4):612-620. doi: 10.1097/SHK.0000000000002081. Epub 2023 Jan 14.
6
Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.基质金属蛋白酶9诱导的肠上皮紧密连接通透性增加会加重实验性葡聚糖硫酸钠(DSS)结肠炎的严重程度。
Am J Physiol Gastrointest Liver Physiol. 2015 Dec 15;309(12):G988-97. doi: 10.1152/ajpgi.00256.2015. Epub 2015 Oct 29.
7
Myosin light chain kinase mediates intestinal barrier disruption following burn injury.肌球蛋白轻链激酶介导烧伤后肠道屏障破坏。
PLoS One. 2012;7(4):e34946. doi: 10.1371/journal.pone.0034946. Epub 2012 Apr 18.
8
1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.1,25-二羟基维生素D通过调节肌球蛋白轻链激酶信号通路保护肠上皮屏障。
Inflamm Bowel Dis. 2015 Nov;21(11):2495-506. doi: 10.1097/MIB.0000000000000526.
9
Overexpression of BCL-2 in the Intestinal Epithelium Prevents Sepsis-Induced Gut Barrier Dysfunction via Altering Tight Junction Protein Expression.BCL-2 在肠上皮中的过表达通过改变紧密连接蛋白表达预防脓毒症诱导的肠道屏障功能障碍。
Shock. 2020 Sep;54(3):330-336. doi: 10.1097/SHK.0000000000001463.
10
Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.汉防己甲素通过肌球蛋白轻链激酶/pMLC2 通路改善肠道上皮屏障功能缓解结肠炎。
Phytomedicine. 2020 Mar;68:153179. doi: 10.1016/j.phymed.2020.153179. Epub 2020 Feb 3.

引用本文的文献

1
Gut integrity in intensive care: alterations in host permeability and the microbiome as potential therapeutic targets.重症监护中的肠道完整性:宿主通透性和微生物群的改变作为潜在治疗靶点
J Intensive Care. 2025 Mar 18;13(1):16. doi: 10.1186/s40560-025-00786-y.
2
A review of gut failure as a cause and consequence of critical illness.作为危重病病因及后果的肠衰竭综述。
Crit Care. 2025 Feb 26;29(1):91. doi: 10.1186/s13054-025-05309-7.
3
Gut Microbiota and Liver Dysfunction in Sepsis: The Role of Inflammatory Mediators and Therapeutic Approaches.脓毒症中的肠道微生物群与肝功能障碍:炎症介质的作用及治疗方法
Int J Mol Sci. 2024 Dec 14;25(24):13415. doi: 10.3390/ijms252413415.
4
Wall of Resilience: How the Intestinal Epithelium Prevents Inflammatory Onslaught in the Gut.韧性之壁:肠道上皮如何预防肠道炎症侵袭
Cell Mol Gastroenterol Hepatol. 2025;19(2):101423. doi: 10.1016/j.jcmgh.2024.101423. Epub 2024 Oct 24.
5
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy.脓毒症中的肠道微生物群:从失调到个性化治疗。
J Clin Med. 2024 Oct 12;13(20):6082. doi: 10.3390/jcm13206082.
6
Slit2-Robo4 signal pathway and tight junction in intestine mediate LPS-induced inflammation in mice.Slit2-Robo4 信号通路和肠道紧密连接介导 LPS 诱导的小鼠炎症反应。
Eur J Med Res. 2024 Jun 27;29(1):349. doi: 10.1186/s40001-024-01894-5.
7
Exploring the lung-gut direction of the gut-lung axis in patients with ARDS.探讨 ARDS 患者的“肠-肺轴的肺-肠方向”。
Crit Care. 2024 May 27;28(1):179. doi: 10.1186/s13054-024-04966-4.
8
Targeting sting to reduce sepsis-induced acute intestinal injury.靶向蜂毒以减轻脓毒症诱导的急性肠道损伤。
Surgery. 2023 Oct;174(4):1071-1077. doi: 10.1016/j.surg.2023.06.032. Epub 2023 Jul 29.
9
Gut Microbiome in Sepsis.脓毒症中的肠道微生物组。
Surg Infect (Larchmt). 2023 Apr;24(3):250-257. doi: 10.1089/sur.2022.420.
10
Contribution of gut microbiota toward renal function in sepsis.肠道微生物群对脓毒症肾功能的影响。
Front Microbiol. 2022 Sep 6;13:985283. doi: 10.3389/fmicb.2022.985283. eCollection 2022.

本文引用的文献

1
The intestinal microenvironment in sepsis.脓毒症的肠道微环境。
Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt B):2574-2583. doi: 10.1016/j.bbadis.2017.03.005. Epub 2017 Mar 7.
2
Pathophysiology of the Gut and the Microbiome in the Host Response.肠道及微生物群在宿主反应中的病理生理学
Pediatr Crit Care Med. 2017 Mar;18(3_suppl Suppl 1):S46-S49. doi: 10.1097/PCC.0000000000001046.
3
Collapse of the Microbiome, Emergence of the Pathobiome, and the Immunopathology of Sepsis.微生物群的崩溃、致病生物群的出现与脓毒症的免疫病理学
Crit Care Med. 2017 Feb;45(2):337-347. doi: 10.1097/CCM.0000000000002172.
4
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症与脓毒性休克管理国际指南:2016版
Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.
5
RAGE-Mediated Suppression of Interleukin-10 Results in Enhanced Mortality in a Murine Model of Acinetobacter baumannii Sepsis.RAGE介导的白细胞介素-10抑制导致鲍曼不动杆菌败血症小鼠模型死亡率增加。
Infect Immun. 2017 Feb 23;85(3). doi: 10.1128/IAI.00954-16. Print 2017 Mar.
6
Extreme Dysbiosis of the Microbiome in Critical Illness.危重病患者的微生物组极度失调。
mSphere. 2016 Aug 31;1(4). doi: 10.1128/mSphere.00199-16. eCollection 2016 Jul-Aug.
7
Variants in LTA, TNF, IL1B and IL10 genes associated with the clinical course of sepsis.LTA、TNF、IL1B和IL10基因的变异与脓毒症的临床病程相关。
Immunol Res. 2016 Dec;64(5-6):1168-1178. doi: 10.1007/s12026-016-8860-4.
8
Mechanisms of Intestinal Barrier Dysfunction in Sepsis.脓毒症中肠屏障功能障碍的机制
Shock. 2016 Jul;46(1):52-9. doi: 10.1097/SHK.0000000000000565.
9
Neutralization of IL-6 and TNF-α ameliorates intestinal permeability in DSS-induced colitis.中和白细胞介素-6和肿瘤坏死因子-α可改善葡聚糖硫酸钠诱导的结肠炎中的肠道通透性。
Cytokine. 2016 Jul;83:189-192. doi: 10.1016/j.cyto.2016.04.012. Epub 2016 May 6.
10
Murine Lung Cancer Increases CD4+ T Cell Apoptosis and Decreases Gut Proliferative Capacity in Sepsis.小鼠肺癌增加脓毒症中CD4+ T细胞凋亡并降低肠道增殖能力。
PLoS One. 2016 Mar 28;11(3):e0149069. doi: 10.1371/journal.pone.0149069. eCollection 2016.

肌球蛋白轻链激酶敲除可改善肠道屏障功能,并在多微生物脓毒症中提供生存优势。

Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.

机构信息

Department of Urology, Emory University School of Medicine, Atlanta, GA.

Department of Surgery and Emory Critical Care Center, Emory University School of Medicine, Atlanta, GA.

出版信息

Mol Med. 2017 Aug;23:155-165. doi: 10.2119/molmed.2016.00256. Epub 2017 Jun 7.

DOI:10.2119/molmed.2016.00256
PMID:28598488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5568914/
Abstract

Sepsis-induced intestinal hyperpermeability is mediated by disruption of the epithelial tight junction, which is closely associated with the peri-junctional actin-myosin ring. Myosin light chain kinase (MLCK) phosphorylates the myosin regulatory light chain, resulting in increased permeability. The purpose of this study was to determine whether genetic deletion of MLCK would alter gut barrier function and survival from sepsis. MLCK and wild type (WT) mice were subjected to cecal ligation and puncture and assayed for both survival and mechanistic studies. Survival was significantly increased in MLCK mice (95% vs. 24%, p<0.0001). Intestinal permeability increased in septic WT mice compared to unmanipulated mice. In contrast, permeability in septic MLCK mice was similar to that seen in unmanipulated animals. Improved gut barrier function in MLCK mice was associated with increases in the tight junction mediators ZO-1 and claudin 15 without alterations in claudin 1, 2, 3, 4, 5, 7, 8, 13, occludin or JAM-A. Other components of intestinal integrity (apoptosis, proliferation and villus length) were unaffected by MLCK deletion as were local peritoneal inflammation and distant lung injury. Systemic IL-10 was decreased greater than 10-fold in MLCK mice; however, survival was similar between septic MLCK mice given exogenous IL-10 or vehicle. These data demonstrate that deletion of MLCK improves survival following sepsis, associated with normalization of intestinal permeability and selected tight junction proteins.

摘要

脓毒症诱导的肠道通透性增加是由上皮紧密连接的破坏介导的,而紧密连接与周围的肌动球蛋白环密切相关。肌球蛋白轻链激酶(MLCK)磷酸化肌球蛋白调节轻链,导致通透性增加。本研究旨在确定 MLCK 的基因缺失是否会改变肠道屏障功能和脓毒症的存活率。对 MLCK 和野生型(WT)小鼠进行盲肠结扎和穿孔,并进行存活和机制研究。MLCK 小鼠的存活率显著增加(95% vs. 24%,p<0.0001)。与未处理的小鼠相比,脓毒症 WT 小鼠的肠道通透性增加。相比之下,脓毒症 MLCK 小鼠的通透性与未处理的动物相似。MLCK 小鼠的肠道屏障功能改善与紧密连接介体 ZO-1 和 Claudin 15 的增加有关,而 Claudin 1、2、3、4、5、7、8、13、occludin 或 JAM-A 没有改变。肠道完整性的其他成分(凋亡、增殖和绒毛长度)不受 MLCK 缺失的影响,局部腹膜炎症和远处肺损伤也是如此。MLCK 小鼠的全身 IL-10 减少了 10 多倍;然而,给予外源性 IL-10 或载体的脓毒症 MLCK 小鼠的存活率相似。这些数据表明,MLCK 的缺失可改善脓毒症后的存活率,与肠道通透性和选定的紧密连接蛋白的正常化相关。